Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glycocalyx | 15 | 2024 | 94 | 5.160 |
Why?
|
Heparitin Sulfate | 17 | 2024 | 224 | 4.350 |
Why?
|
Lung Injury | 11 | 2024 | 424 | 3.730 |
Why?
|
Glycosaminoglycans | 8 | 2023 | 605 | 2.910 |
Why?
|
Sepsis | 19 | 2024 | 2592 | 2.770 |
Why?
|
Endothelium | 5 | 2019 | 764 | 1.740 |
Why?
|
Acute Lung Injury | 9 | 2024 | 367 | 1.670 |
Why?
|
Lung | 26 | 2024 | 9994 | 1.620 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2023 | 237 | 1.430 |
Why?
|
Endothelium, Vascular | 8 | 2024 | 4434 | 1.030 |
Why?
|
Respiratory Insufficiency | 5 | 2023 | 1231 | 0.970 |
Why?
|
Endotoxemia | 2 | 2018 | 196 | 0.940 |
Why?
|
Pneumonia, Bacterial | 2 | 2023 | 319 | 0.860 |
Why?
|
Oligosaccharides | 4 | 2023 | 405 | 0.820 |
Why?
|
Fellowships and Scholarships | 4 | 2024 | 1116 | 0.800 |
Why?
|
Pneumonia | 5 | 2022 | 2131 | 0.800 |
Why?
|
Silver Staining | 1 | 2021 | 63 | 0.760 |
Why?
|
Fluid Therapy | 3 | 2019 | 579 | 0.740 |
Why?
|
Glucuronidase | 5 | 2020 | 202 | 0.740 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 143 | 0.740 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2021 | 112 | 0.730 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 694 | 0.690 |
Why?
|
Endothelial Cells | 8 | 2024 | 3539 | 0.680 |
Why?
|
Neutrophils | 5 | 2017 | 3767 | 0.660 |
Why?
|
Critical Illness | 4 | 2022 | 2709 | 0.650 |
Why?
|
Sulfotransferases | 1 | 2019 | 149 | 0.640 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1744 | 0.620 |
Why?
|
Heparin | 4 | 2020 | 1652 | 0.620 |
Why?
|
Interleukin-18 | 1 | 2020 | 251 | 0.620 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 349 | 0.560 |
Why?
|
Bleomycin | 3 | 2020 | 495 | 0.560 |
Why?
|
Shock | 1 | 2018 | 317 | 0.530 |
Why?
|
Cell Communication | 3 | 2017 | 1653 | 0.520 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2017 | 590 | 0.490 |
Why?
|
Animals | 45 | 2024 | 167960 | 0.470 |
Why?
|
Mice | 28 | 2024 | 81209 | 0.450 |
Why?
|
Capillary Permeability | 3 | 2018 | 768 | 0.450 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 858 | 0.410 |
Why?
|
Ephrin-A1 | 1 | 2012 | 9 | 0.410 |
Why?
|
Chondroitin Sulfates | 4 | 2023 | 174 | 0.400 |
Why?
|
Lipopolysaccharides | 5 | 2024 | 2209 | 0.400 |
Why?
|
Receptor, EphA2 | 1 | 2012 | 41 | 0.400 |
Why?
|
Gap Junctions | 1 | 2013 | 230 | 0.390 |
Why?
|
Memory Disorders | 1 | 2019 | 1197 | 0.390 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 161 | 0.390 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2012 | 119 | 0.380 |
Why?
|
Influenza, Human | 1 | 2022 | 1528 | 0.380 |
Why?
|
Acute Kidney Injury | 4 | 2019 | 1941 | 0.350 |
Why?
|
Shock, Septic | 1 | 2016 | 760 | 0.340 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 1602 | 0.340 |
Why?
|
Hippocampus | 2 | 2019 | 3738 | 0.330 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2008 | 2 | 0.330 |
Why?
|
Pulmonary Alveoli | 4 | 2024 | 653 | 0.320 |
Why?
|
Virulence | 2 | 2023 | 1298 | 0.320 |
Why?
|
Hyperoxia | 1 | 2011 | 250 | 0.320 |
Why?
|
Wounds and Injuries | 2 | 2024 | 2477 | 0.320 |
Why?
|
Editorial Policies | 2 | 2024 | 457 | 0.300 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.300 |
Why?
|
Guanylate Cyclase | 1 | 2008 | 205 | 0.300 |
Why?
|
Antiviral Agents | 1 | 2020 | 3061 | 0.290 |
Why?
|
Hyperalgesia | 1 | 2012 | 530 | 0.290 |
Why?
|
Syndecan-1 | 4 | 2023 | 163 | 0.290 |
Why?
|
Histones | 1 | 2017 | 2582 | 0.290 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1972 | 0.280 |
Why?
|
Humans | 56 | 2024 | 760613 | 0.270 |
Why?
|
Endotoxins | 3 | 2020 | 521 | 0.270 |
Why?
|
Resuscitation | 3 | 2019 | 661 | 0.260 |
Why?
|
Mice, Inbred C57BL | 12 | 2024 | 22020 | 0.260 |
Why?
|
Colorado | 2 | 2016 | 164 | 0.260 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2058 | 0.250 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1570 | 0.240 |
Why?
|
Inflammation | 6 | 2022 | 10755 | 0.240 |
Why?
|
Respiratory Function Tests | 3 | 2020 | 1683 | 0.240 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2024 | 60 | 0.240 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1190 | 0.240 |
Why?
|
Anticoagulants | 1 | 2020 | 4897 | 0.230 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11902 | 0.230 |
Why?
|
Hospital Mortality | 2 | 2017 | 5418 | 0.220 |
Why?
|
Angiopoietin-2 | 2 | 2024 | 172 | 0.210 |
Why?
|
Staphylococcal Infections | 2 | 2024 | 1407 | 0.210 |
Why?
|
Rodentia | 1 | 2024 | 260 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18137 | 0.200 |
Why?
|
Cytotoxins | 1 | 2022 | 153 | 0.200 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 250 | 0.200 |
Why?
|
Signal Transduction | 5 | 2024 | 23374 | 0.200 |
Why?
|
Cell Adhesion | 3 | 2013 | 3094 | 0.190 |
Why?
|
Ion Exchange | 1 | 2021 | 16 | 0.190 |
Why?
|
Calcitonin | 1 | 2022 | 330 | 0.190 |
Why?
|
Mice, Knockout | 7 | 2024 | 14374 | 0.190 |
Why?
|
Desiccation | 1 | 2021 | 78 | 0.190 |
Why?
|
Plasma | 1 | 2024 | 584 | 0.180 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2192 | 0.180 |
Why?
|
Solutions | 1 | 2021 | 419 | 0.180 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2622 | 0.170 |
Why?
|
Male | 26 | 2024 | 359718 | 0.170 |
Why?
|
Pneumococcal Infections | 1 | 2004 | 503 | 0.170 |
Why?
|
Atherosclerosis | 1 | 2016 | 3518 | 0.170 |
Why?
|
Blood Specimen Collection | 1 | 2020 | 238 | 0.160 |
Why?
|
Pulmonary Medicine | 1 | 2021 | 221 | 0.160 |
Why?
|
Thrombomodulin | 1 | 2019 | 105 | 0.160 |
Why?
|
Syndecans | 1 | 2018 | 75 | 0.160 |
Why?
|
Apoptosis | 2 | 2014 | 9497 | 0.160 |
Why?
|
Research Report | 1 | 2022 | 370 | 0.160 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 599 | 0.150 |
Why?
|
Atrial Natriuretic Factor | 1 | 2019 | 350 | 0.150 |
Why?
|
Patient Positioning | 1 | 2021 | 327 | 0.150 |
Why?
|
Protein Precursors | 1 | 2022 | 1134 | 0.150 |
Why?
|
Bacterial Adhesion | 1 | 2019 | 306 | 0.150 |
Why?
|
Diagnosis, Differential | 2 | 2023 | 12968 | 0.150 |
Why?
|
Polysaccharide-Lyases | 1 | 2017 | 47 | 0.150 |
Why?
|
Glucuronides | 1 | 2017 | 20 | 0.140 |
Why?
|
Long-Term Potentiation | 1 | 2019 | 293 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 538 | 0.140 |
Why?
|
Alkalies | 1 | 2017 | 44 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9591 | 0.140 |
Why?
|
von Willebrand Factor | 1 | 2021 | 673 | 0.140 |
Why?
|
Cecum | 1 | 2017 | 232 | 0.140 |
Why?
|
Toll-Like Receptor 9 | 1 | 2018 | 235 | 0.140 |
Why?
|
Ligation | 1 | 2017 | 448 | 0.130 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2017 | 167 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 256 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 558 | 0.130 |
Why?
|
Sheep | 1 | 2018 | 1441 | 0.130 |
Why?
|
Punctures | 1 | 2017 | 368 | 0.130 |
Why?
|
Staphylococcus aureus | 2 | 2024 | 1462 | 0.120 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2006 | 1463 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2024 | 7850 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2016 | 478 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2012 | 3602 | 0.120 |
Why?
|
Transcription Factors | 1 | 2014 | 12102 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2017 | 3663 | 0.120 |
Why?
|
Aged | 9 | 2023 | 169143 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9952 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2019 | 1130 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 911 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15286 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1469 | 0.110 |
Why?
|
Thoracostomy | 1 | 2013 | 74 | 0.100 |
Why?
|
Nicotine | 1 | 2017 | 677 | 0.100 |
Why?
|
Bacteria | 1 | 2023 | 2199 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 730 | 0.100 |
Why?
|
Chemokine CXCL1 | 1 | 2012 | 106 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4356 | 0.100 |
Why?
|
Sex Factors | 2 | 2024 | 10546 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 257 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 812 | 0.090 |
Why?
|
MicroRNAs | 2 | 2017 | 3787 | 0.090 |
Why?
|
Prognosis | 3 | 2022 | 29661 | 0.090 |
Why?
|
Microcirculation | 1 | 2016 | 1278 | 0.090 |
Why?
|
Anemia | 1 | 2020 | 1511 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8623 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2019 | 1716 | 0.090 |
Why?
|
Female | 16 | 2024 | 391246 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 250 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2024 | 3825 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2471 | 0.090 |
Why?
|
Matrix Metalloproteinases | 2 | 2024 | 392 | 0.090 |
Why?
|
Adoptive Transfer | 1 | 2012 | 822 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 605 | 0.080 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 2008 | 100 | 0.080 |
Why?
|
Blood-Air Barrier | 1 | 2008 | 24 | 0.080 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 802 | 0.080 |
Why?
|
Erythrocytes | 1 | 2018 | 2415 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2012 | 1126 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1669 | 0.080 |
Why?
|
Burns | 1 | 2019 | 1866 | 0.080 |
Why?
|
Fibrosis | 1 | 2015 | 2042 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
|
Cyclic GMP | 1 | 2008 | 395 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 3051 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1726 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2022 | 9530 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3795 | 0.070 |
Why?
|
Adult | 8 | 2023 | 220007 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3306 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2015 | 1155 | 0.070 |
Why?
|
Partial Pressure | 1 | 2006 | 245 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7268 | 0.060 |
Why?
|
Water | 1 | 2012 | 1407 | 0.060 |
Why?
|
Respiratory Muscles | 1 | 2006 | 142 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2008 | 1456 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 151 | 0.060 |
Why?
|
Decorin | 1 | 2023 | 38 | 0.060 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2004 | 187 | 0.060 |
Why?
|
Aging | 1 | 2023 | 8652 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2017 | 428 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2873 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1173 | 0.060 |
Why?
|
Cathelicidins | 1 | 2023 | 81 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2896 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2027 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20080 | 0.060 |
Why?
|
Trypsin | 1 | 2024 | 496 | 0.050 |
Why?
|
NF-kappa B | 1 | 2012 | 2486 | 0.050 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.050 |
Why?
|
Disaccharides | 1 | 2023 | 170 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3736 | 0.050 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2004 | 418 | 0.050 |
Why?
|
Adolescent | 4 | 2024 | 87809 | 0.050 |
Why?
|
Time Factors | 2 | 2022 | 40139 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2519 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 220359 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2421 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3524 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 58748 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2024 | 482 | 0.050 |
Why?
|
Child | 3 | 2024 | 79799 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2023 | 354 | 0.050 |
Why?
|
Carbon Dioxide | 1 | 2006 | 1146 | 0.050 |
Why?
|
United States | 3 | 2024 | 72448 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9288 | 0.050 |
Why?
|
Cell Movement | 1 | 2013 | 5206 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2024 | 623 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
Prospective Studies | 3 | 2024 | 54306 | 0.050 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2024 | 448 | 0.040 |
Why?
|
Proteoglycans | 1 | 2023 | 801 | 0.040 |
Why?
|
Cricetulus | 1 | 2022 | 815 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1832 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 196 | 0.040 |
Why?
|
Rehydration Solutions | 1 | 2019 | 43 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2141 | 0.040 |
Why?
|
Biofilms | 1 | 2024 | 621 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.040 |
Why?
|
Thorax | 1 | 2022 | 553 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 3047 | 0.040 |
Why?
|
CHO Cells | 1 | 2022 | 1389 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 620 | 0.040 |
Why?
|
Creatinine | 2 | 2015 | 1904 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22052 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2427 | 0.040 |
Why?
|
Financing, Organized | 1 | 2019 | 204 | 0.040 |
Why?
|
Osteoclasts | 1 | 2022 | 712 | 0.040 |
Why?
|
RNA Transport | 1 | 2017 | 45 | 0.040 |
Why?
|
Lectins | 1 | 2019 | 484 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2019 | 449 | 0.040 |
Why?
|
Carbohydrate Conformation | 1 | 2017 | 206 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 12762 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9185 | 0.030 |
Why?
|
Osteoblasts | 1 | 2022 | 1142 | 0.030 |
Why?
|
Indoles | 1 | 2024 | 1829 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13505 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 699 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1156 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 887 | 0.030 |
Why?
|
Fibronectins | 1 | 2019 | 722 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 506 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 848 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1915 | 0.030 |
Why?
|
Protein Conformation | 1 | 2022 | 3970 | 0.030 |
Why?
|
Catheterization | 1 | 2019 | 1432 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2013 | 187 | 0.030 |
Why?
|
Ovalbumin | 1 | 2015 | 674 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2629 | 0.030 |
Why?
|
Lipocalins | 1 | 2013 | 161 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1617 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1652 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 250 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.030 |
Why?
|
Protein Kinases | 1 | 2019 | 1612 | 0.020 |
Why?
|
Teaching | 1 | 2019 | 1169 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2167 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 987 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4122 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1227 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 605 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2754 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8055 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5899 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 719 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80345 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1189 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 1174 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2668 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6216 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8158 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15620 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1943 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7408 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2180 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2017 | 1919 | 0.010 |
Why?
|
Odds Ratio | 1 | 2017 | 9716 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3725 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15840 | 0.010 |
Why?
|
Crohn Disease | 1 | 2017 | 2275 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74333 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3215 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58980 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 41337 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36053 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42056 | 0.010 |
Why?
|
Cognition | 1 | 2019 | 6964 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23709 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25941 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3226 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39262 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18955 | 0.010 |
Why?
|
Hospitalization | 1 | 2017 | 10789 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13982 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64981 | 0.010 |
Why?
|